Quanterix Corporation-Product Pipeline Analysis, 2016 Update

Quanterix Corporation-Product Pipeline Analysis, 2016 Update


  • Products Id :- GDME173706PD
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Quanterix Corporation (Quanterix) is a medical device manufacturer that develops ultra-sensitive diagnostic platform for measuring individual proteins. The company's products include simoa HD1 analyzer, assay kits and consumables. It provides assay kits including C-peptide simoa assay kit, homebrew assay kit, homebrew bead and SBG kit, PSA Simoa assay kit, tau simoa assay kit and TNF-a simoa assay kit. Quanterix's products find application in life sciences research, oncology, neurology, inflammatory disease and infectious disease areas. The company also partners with other companies to develop and validate bioassays. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Quanterix Corporation

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Quanterix Corporation Company Snapshot 6

Quanterix Corporation Company Overview 6

Quanterix Corporation Pipeline Products and Clinical Trials Overview 6

Quanterix Corporation-Pipeline Analysis Overview 9

Key Facts 9

Quanterix Corporation-Major Products and Services 10

Quanterix Corporation Pipeline Products by Development Stage 11

Quanterix Corporation Pipeline Products Overview 13

AccuPSA Test 13

AccuPSA Test Product Overview 13

Antigen Detection Assay-Tuberculosis 14

Antigen Detection Assay-Tuberculosis Product Overview 14

Blood Test-Concussions/TBI 15

Blood Test-Concussions/TBI Product Overview 15

Diagnostic Assay-Alzheimer's Disease 16

Diagnostic Assay-Alzheimer's Disease Product Overview 16

Digital ELISA-Crohn's Disease 17

Digital ELISA-Crohn's Disease Product Overview 17

Digital ELISA Assay-C. Difficile 18

Digital ELISA Assay-C. Difficile Product Overview 18

POC Device-Neurological Injuries 19

POC Device-Neurological Injuries Product Overview 19

Simoa 3.0 20

Simoa 3.0 Product Overview 20

Simoa 4.0 21

Simoa 4.0 Product Overview 21

Simoa 5.0 22

Simoa 5.0 Product Overview 22

SiMoA HD-1 Analyzer-Botulinum Toxin Assay 23

SiMoA HD-1 Analyzer-Botulinum Toxin Assay Product Overview 23

SiMoA HD-1 Analyzer-Prostate Cancer Assay 24

SiMoA HD-1 Analyzer-Prostate Cancer Assay Product Overview 24

Quanterix Corporation-Key Competitors 25

Quanterix Corporation-Key Employees 26

Quanterix Corporation-Locations And Subsidiaries 27

Head Office 27

Recent Developments 28

Quanterix Corporation, Recent Developments 28

Jun 15, 2016: Frontage Laboratories Announces Partnership with Quanterix and Validation of Simoa HD-1 Analyzer and Software to Support Biomarker Analysis 28

Apr 18, 2016: Quanterix Opens Call for Proposals for Second Annual Accelerator Grant Program Focused on Oncology and Liquid Tumor Biopsy Technology 28

Mar 03, 2016: Quanterix's Single Molecule Array Technology Unlocks New Biomarker Fueling Advancements in Neurological Research 29

Feb 10, 2016: Quanterix Names Frontage Laboratories as a Preferred Partner in Biomarker Assay Development and Testing Services in the Regulated Space 29

Feb 05, 2016: Quanterix Presented Ultrasensitive Technology at NFL Health and Safety Update & Interactive Head Health Showcase 30

Jan 27, 2016: Quanterix Announces Expansion into Asia Pacific 30

Jan 14, 2016: ABL Offers Quanterix Diagnostic Platform for Ultrasensitive Biomarker Detection Through Platine Pharma Services Subsidiary 31

Nov 17, 2015: Quanterix's Ultrasensitive Single Molecule Measurement Technology Featured in Clinical Chemistry 31

Oct 28, 2015: Quanterix Launches Next Generation Simoa 2.0 Ultrasensitive Immunoassay Platform 32

Aug 26, 2015: Researchers Use Quanterix's Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes 32

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 35

List of Figures

Quanterix Corporation Pipeline Products by Equipment Type 7

Quanterix Corporation Pipeline Products by Development Stage 11

List of Tables

Quanterix Corporation Pipeline Products and Clinical Trials Overview 6

Quanterix Corporation Pipeline Products by Equipment Type 7

Quanterix Corporation Pipeline Products by Indication 8

Quanterix Corporation, Key Facts 9

Quanterix Corporation, Major Products and Services 10

Quanterix Corporation Number of Pipeline Products by Development Stage 11

Quanterix Corporation Pipeline Products Summary by Development Stage 12

AccuPSA Test-Product Status 13

AccuPSA Test-Product Description 13

Antigen Detection Assay-Tuberculosis-Product Status 14

Antigen Detection Assay-Tuberculosis-Product Description 14

Blood Test-Concussions/TBI-Product Status 15

Blood Test-Concussions/TBI-Product Description 15

Diagnostic Assay-Alzheimer's Disease-Product Status 16

Diagnostic Assay-Alzheimer's Disease-Product Description 16

Digital ELISA-Crohn's Disease-Product Status 17

Digital ELISA-Crohn's Disease-Product Description 17

Digital ELISA Assay-C. Difficile-Product Status 18

Digital ELISA Assay-C. Difficile-Product Description 18

POC Device-Neurological Injuries-Product Status 19

POC Device-Neurological Injuries-Product Description 19

Simoa 3.0-Product Status 20

Simoa 3.0-Product Description 20

Simoa 4.0-Product Status 21

Simoa 4.0-Product Description 21

Simoa 5.0-Product Status 22

Simoa 5.0-Product Description 22

SiMoA HD-1 Analyzer-Botulinum Toxin Assay-Product Status 23

SiMoA HD-1 Analyzer-Botulinum Toxin Assay-Product Description 23

SiMoA HD-1 Analyzer-Prostate Cancer Assay-Product Status 24

SiMoA HD-1 Analyzer-Prostate Cancer Assay-Product Description 24

Quanterix Corporation, Key Employees 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Quanterix Corporation, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 50198
Site License
USD 1,500 INR 67
Corporate User License
USD 2,250 INR 134

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com